Back to Search
TYLER FITCH, M.D.
M.D.
Internal Medicine Physician
NPI: 1992068936IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
125.061142(IL)
Pediatrics Physician
Pediatrics
Code: 208000000X
125.061142(IL)
Education
OTHER
Class of 2008
Research & Publications (20)
Dopamine D1/5 receptor modulation of firing rate and bidirectional theta burst firing in medial septal/vertical limb of diagonal band neurons in vivo.
PMID 16452256·J Neurophysiol·2006
4-observational
Force transducer-based movement detection in fear conditioning in mice: a comparative analysis.
PMID 11918287·Hippocampus·2002
4-observational
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
PMID 19380443·J Clin Oncol·2009
3-trial
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
PMID 19129205·Ann Oncol·2009
3-trial
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
PMID 19090009·Cancer·2009
3-trial
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
PMID 19047293·J Clin Oncol·2009
3-trial
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
PMID 18045731·Lung Cancer·2008
3-trial
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
PMID 17674351·Cancer·2007
2-rct
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
PMID 17921712·Am J Clin Oncol·2007
3-trial
Constructions and deconstructions of risk, resilience and wellbeing: a model for understanding the development of Aboriginal adolescents.
PMID 18027130·Australas Psychiatry·2007
8-other
Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.
PMID 19023677·J Gastrointest Cancer·2007
3-trial
Locus of control and academic achievement in high school students.
PMID 16796083·Psychol Rep·2006
8-other
Phase II study of erlotinib in patients with advanced biliary cancer.
PMID 16809731·J Clin Oncol·2006
3-trial
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
PMID 16782922·J Clin Oncol·2006
3-trial
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
PMID 16505409·J Clin Oncol·2006
3-trial
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
PMID 16520332·Ann Oncol·2006
3-trial
Metastatic prostate carcinoma mimicking meningioma: case report and review of the literature.
PMID 16547447·Neurologist·2006
5-case
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
PMID 16730134·Int J Radiat Oncol Biol Phys·2006
3-trial
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
PMID 16770976·Mayo Clin Proc·2006
3-trial
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
PMID 16503551·Haematologica·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 530 NE GLEN OAK AVE, #5607
PEORIA, IL 61637 - Phone
- (309) 655-3863
Quick Facts
- NPI
- 1992068936
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile